Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

AI virtual cell uses protein dynamics to predict personalized breast cancer treatments (opens in a new tab)

medicalxpress.com · 2026-09-12

Short answerEvidenceSource

Short answer

Needs review

Study found.

We found the study, but the claim check did not finish.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

We found the study behind this story.

We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.

Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.

Claim 1 of 7Not checkedA new AI tool called ProteinTalks can predict whether a drug will be effective against a cancer cell line, find new drug combinations, and identify proteins linked to drug resistance.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 2 of 7Not checkedAccording to the report published in Nature, ProteinTalks outperformed existing AI models based on gene activity and traditional machine-learning methods in predicting how cancer cells respond to drugs.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 3 of 7Not checkedThe team captured more than 38 million protein measurements to map how breast cancer cells respond to 63 FDA-approved anticancer drugs and 59 two-drug combinations, sampling before treatment and at 6, 24 and 48 hours.View evidenceHide evidence

As statedmore than 38 million protein measurements

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 4 of 7Not checkedIt accurately predicted responses to 81 anticancer compounds it had never seen during training and revealed four drug pairs that showed a stronger effect together than either drug alone against triple-negative breast cancer.View evidenceHide evidence

As stated81 anticancer compounds; four drug pairs

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 5 of 7Not checkedThe model also successfully predicted cell responses to lung, colorectal, pancreatic and melanoma cancer cells, even though it was trained on breast cancer cell lines.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 6 of 7Not checkedBy tracking protein changes over time, the model pinpointed key drivers of drug resistance; one example was AKR1C3, where knocking down the protein restored sensitivity to docetaxel, confirmed through cytotoxicity assays.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 7 of 7Not checkedThe platform analyzed protein signatures in 501 triple-negative breast cancer tumors and, by screening more than 3,000 repurposed drugs against patient-derived organoids, pinpointed personalized drug candidates and promising synergistic combinations.View evidenceHide evidence

As stated501 tumors; more than 3,000 repurposed drugs

Not checked

The source study was found, but this claim couldn't be checked against it.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 16 candidate papers

And 10 more candidates considered.